Examining The U.S. Government’S Accelerated Efforts To Develop Vaccines And Therapeutics To Protect Against And Treat The Ebola Epidemic
- Looking at BARDA’s efforts to partner with the biotech industry to make products a reality
- Discussing process steps for rapid development and manufacturing of drug candidates
- How U.S. medical countermeasure response infrastructure can be applied to other industries to rapidly develop pipeline products
- Examining pathway to licensure of pandemic vaccines and the work on second generation products